Precocious Puberty Secondary to Topical Testosterone Transfer: A Case Report

Journal of Sexual Medicine

Volumn 8, Issue 2, 2011, Pages 622-626

  Cavender, Richard K ^a   Fairall, Melissa ^a  

^a Ohio Center for Sexual Medicine   (United States)

Author keywords

Environmental exposure; Hormone replacement therapy; Precocious puberty

Indexed keywords

ANASTROZOLE; TESTOSTERONE;

ADULT; ARTICLE; ASPERGER SYNDROME; BEDTIME DOSAGE; CASE REPORT; CHILD DEVELOPMENT; CONGENITAL ADRENAL HYPERPLASIA; ENVIRONMENTAL EXPOSURE; HEALTH CARE PERSONNEL; HORMONE SUBSTITUTION; HORMONE TRANSPORT; HUMAN; HYPOGONADISM; INFANT; MALE; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL;

EID: 79551472047     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02082.x     Document Type: Article

References (11)

1. Food and Drug Administration. FDA Approved Drug Products. Available at: (accessed October 16, 2009).
2. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FCW. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121-30.
3. Yu YM, Punyasavatsu N, Elder D, D'Ercole AJ. Sexual development in a two-year-old boy induced by topical exposure to testosterone. Pediatrics 1999;104:e23.
4. Moore N, Paux G, Noblet C, Andrejak M. Spouse-related drug side-effects. Lancet 1988;1:468.
5. Delanoe D, Fougeyrollas B, Meyer L, Thonneau P. Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception. Lancet 1984;1:276.
6. de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies. Hum Reprod 2009;24:425-8.
7. US Food and Drug Administration. FDA News: Testosterone Gel Safety Concerns Prompt FDA to Require Label Changes, Medication Guide. 2009. Available at: (accessed December 3, 2009).
8. Lewis T, Goldstein I. Transfer of topical testosterone preparations to children or spouses. J Sex Med 2009;6:2649-52.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Text Revision ed. Washington, DC: American Psychiatric Association; 2000.
10. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC. The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007;28:235-58.
11. Cavender RK, Fairall M. Subcutaneous testosterone pellet implant (Testopel) therapy for men with testosterone deficiency syndrome: A single-site retrospective safety analysis. J Sex Med 2009;6:3177-92.